Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight.
Priyanka SaklaniHeena KhanThakur Gurjeet SinghSaurabh GuptaAmarjot Kaur GrewalPublished in: Molecular biology reports (2022)
This review focus on the neuroprotective potential of demethyleneberberine in neurodegenerative disorders by attenuating different pathways, i.e., NF-κB, MAPK, and AMPK signalling.